SyrSpend® SF Publication overview

For detailled information on the used SyrSpend® SF vehicles and storage conditions applied in the stability studies please be referred to the published articles. 

Active ingredient

Concentration

Beyond-use date

Publication

Baclofen 2 mg/ml 90 days Link to article
Carvedilol 5 mg/ml 90 days Link to article
Celecoxib 10 mg/ml 90 days Link to article
Chloral hydrate 100 mg/ml 60 days Link to article
Cyclosporin 100 mg/ml 90 days Link to article
Flecainide acetate 20 mg/ml 90 days Link to article
Glycopyrrolate (glycopyrronium bromide) 0.5 mg/ml

90 days

Link to article
Hydrochlorothiazide 2 mg/ml 90 days Link to article
Hydrocortisone 1 mg/ml 90 days Link to article
Itraconazole 20 mg/ml 90 days Link to article
Melatonin 3 mg/ml 90 days Link to article
Nitrendipine 5 mg/ml 60 days Link to article
Oseltamivir phosphate 6 mg/ml 90 days

Link to article

Phenobarbital 9 mg/ml 90 days/154 days Link to article
Phenobarbital 15 mg/ml 90 days Link to article
Prednisolone 5 mg/ml

60 days

Link to article
Propranolol HCL 0.5 mg/ml 90 days Link to article
Propranolol HCL 5 mg/ml 90 days Link to article
Pyrazinamide 100 mg/ml 90 days Link to article
Rabeprazole 3 mg/ml Not stable Link to article
Tacrolimus 0.5 mg/ml 90 days Link to article
Ursodiol 20 mg/ml 90 days Link to article
Vancomycin HCL 25 mg/ml 90 days Link to article
Warfarin sodium 1 mg/ml 44 days/10 days Link to article
       

For a complete overview of all studied APIs in SyrSpend® SF please request the SyrSpend® SF compatibility table at your local Fagron company.